Cargando…
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
BACKGROUND: Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax. RESULTS: Conservative treatment lead to a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327395/ https://www.ncbi.nlm.nih.gov/pubmed/30626415 http://dx.doi.org/10.1186/s13023-018-0991-3 |
_version_ | 1783386456375427072 |
---|---|
author | Pospiskova, Jana Smolej, Lukas Belada, David Simkovic, Martin Motyckova, Monika Sykorova, Alice Stepankova, Pavla Zak, Pavel |
author_facet | Pospiskova, Jana Smolej, Lukas Belada, David Simkovic, Martin Motyckova, Monika Sykorova, Alice Stepankova, Pavla Zak, Pavel |
author_sort | Pospiskova, Jana |
collection | PubMed |
description | BACKGROUND: Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax. RESULTS: Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients. CONCLUSION: Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax. |
format | Online Article Text |
id | pubmed-6327395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63273952019-01-15 Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders Pospiskova, Jana Smolej, Lukas Belada, David Simkovic, Martin Motyckova, Monika Sykorova, Alice Stepankova, Pavla Zak, Pavel Orphanet J Rare Dis Research BACKGROUND: Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax. RESULTS: Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients. CONCLUSION: Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax. BioMed Central 2019-01-09 /pmc/articles/PMC6327395/ /pubmed/30626415 http://dx.doi.org/10.1186/s13023-018-0991-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Pospiskova, Jana Smolej, Lukas Belada, David Simkovic, Martin Motyckova, Monika Sykorova, Alice Stepankova, Pavla Zak, Pavel Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title | Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title_full | Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title_fullStr | Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title_full_unstemmed | Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title_short | Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
title_sort | experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327395/ https://www.ncbi.nlm.nih.gov/pubmed/30626415 http://dx.doi.org/10.1186/s13023-018-0991-3 |
work_keys_str_mv | AT pospiskovajana experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT smolejlukas experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT beladadavid experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT simkovicmartin experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT motyckovamonika experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT sykorovaalice experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT stepankovapavla experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders AT zakpavel experiencesinthetreatmentofrefractorychylothoraxassociatedwithlymphoproliferativedisorders |